Watch Ticker

Pasithea Therapeutics Corp. Common Stock

Go to Pasithea Therapeutics Corp. Common Stock Website

$0.69

0.00 (-0.01%)

Live

Previous Close

$0.6903

Day Range

$0.69 - $0.690262

Previous Day Range

$0.681 - $0.6966

Market Cap

$5.3 million USD

Day Vol.

2378

Previous Day Vol.

20267

Currency

USD

Primary Exchange

Nasdaq

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Neurofibromatosis Type 1 Market Set to Witness Significant Growth During the Study Period (2020–2034) Driven by Advances in Treatment | DelveInsight

The neurofibromatosis type 1 market is expected to grow significantly due to advances in treatment, increased diagnoses, and ongoing clinical trials. Unmet needs in adult populations and systemic disease management create opportunities for new entrants and differentiated strategies.

Related tickers: KTTA, KTTAW, AZN, MRK, SWTX.

Read Full Article

N/A - Pasithea Therapeutics Announces Closing of $5 Million Public Offering

Pasithea Therapeutics, a clinical-stage biotechnology company, announced the closing of a $5 million public offering to fund its ongoing research, clinical trials, and corporate initiatives.

Related tickers: KTTA, KTTAW.

Read Full Article

Trending Tickers

Please sign in to view